Feature: Will antibodies finally put an end to migraines? | Science/AAAS | News


Targeting a peptide that may be the long-sought headache trigger, four firms are racing to develop the first truly effective migraine treatment

Original Article

Leave a comment

Your email address will not be published. Required fields are marked *